v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Public Offering [Member]
Common Stock
Common Stock
Market Offering [Member]
Additional Paid-In Capital
Additional Paid-In Capital
Market Offering [Member]
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2024 $ 629,838   $ 10   $ 1,579,750   $ 6 $ (949,928)
Beginning Balance, Shares at Dec. 31, 2024     102,318,629          
Issuance of stock, net of issuance costs   $ 140,653   $ 1   $ 140,652    
Issuance of stock, net of issuance costs, Shares       10,660,159        
Exercise of stock options 588       588      
Exercise of stock options, Shares     89,835          
Stock-based compensation 13,020       13,020      
Vesting of restricted stock units     565,159          
Unrealized gains (losses) on marketable securities 235           235  
Net Income (Loss) (115,361)             (115,361)
Ending Balance at Mar. 31, 2025 668,973   $ 11   1,734,010   241 (1,065,289)
Ending Balance, Shares at Mar. 31, 2025     113,633,782          
Beginning Balance at Dec. 31, 2025 972,129   $ 16   2,367,780   475 (1,396,142)
Beginning Balance, Shares at Dec. 31, 2025     164,950,540          
Exercise of stock options $ 1,311       1,311      
Exercise of stock options, Shares 88,932   88,932          
Stock-based compensation $ 13,081       13,081      
Vesting of restricted stock units     161,857          
Unrealized gains (losses) on marketable securities (612)           (612)  
Net Income (Loss) (120,854)             (120,854)
Ending Balance at Mar. 31, 2026 $ 865,055   $ 16   $ 2,382,172   $ (137) $ (1,516,996)
Ending Balance, Shares at Mar. 31, 2026     165,201,329